Document is current
Any future updates will be listed below
-
Authors
Delbaje, Endrews
Pontes, Laís
Rhodes, Johanna
Steenwyk, Jacob
Lu, Ling
dos Reis, Thaila F.
Rokas, Antonis
Goldman, Gustavo H.
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2021/04977-5 (G.H.G.), 2022/13603-4 (ED), and 2022/09882-5 (LP), 2021/04977-5 (G.H.G.), 2022/13603-4 (ED), and 2022/09882-5 (LP), 2021/04977-5 (G.H.G.), 2022/13603-4 (ED), and 2022/09882-5 (LP))
Wellcome Trust (219551/Z/19/Z)
National Institute of Allergy and Infectious Diseases (grant R01 AI153356 from the USA (to A.R. and G.H.G.), grant R01 AI153356 from the USA (to A.R. and G.H.G.))
Conselho Nacional de Desenvolvimento Científico e Tecnológico (301058/2019-9 and 405934/2022-0)
Canada’s International Development Research Centre (no grant ID)
- License Information
-
More Information
Article History
Received: 3 September 2024
Accepted: 4 February 2025
First Online: 27 February 2025
Competing interests
: J.L.S. is a scientific advisor for WittGen Biotechnologies. J.L.S. is an advisor for ForensisGroup Incorporated. A.R. is a scientific consultant for LifeMine Therapeutics, Inc. G.H.G. is a scientific consultant for Innovation Pharmaceuticals Inc. The other authors declare no other competing interests.
